Neuromyelitis optica in patients with increased interferon alpha concentrations

Jac Williams (1) , Sarah Mcglasson (2) , Sarosh Irani (3) , Darragh Duffy (4) , Yanick Crow (2) , David Hunt (1) , Scottish Nmosd Study Group

1 Anne Rowling Clinic [Edinburgh, UK]
2 Medical Research Council Institute of Genetics and Molecular Medicine [Edinburgh, UK]
3 Oxford Autoimmune Neurology Group [Oxford, UK]
4 Immunobiologie des Cellules dendritiques

Recombinant interferon alpha is used to treat several immunological, oncological, and infectious diseases,1 and various serious side-effects have been associated with its therapeutic use. We want to bring attention to the development of neuromyelitis optica spectrum disorder (NMOSD) [...]

Domains: Life Sciences [q-bio]; Immunology

Jac Williams, Sarah Mcglasson, Sarosh Irani, Darragh Duffy, Yanick Crow, et al.. Neuromyelitis optica in patients with increased interferon alpha concentrations. The Lancet Neurology, 2020, 19 (1), pp.31-33. ⟨10.1016/S1474-4422(19)30445-4⟩. ⟨pasteur-02430155⟩